Neil T Chen

Title: Neil T. Chen: Innovator in Angiogenesis Research

Introduction

Neil T. Chen is a notable inventor based in Newton Center, MA (US). He has made significant contributions to the field of angiogenesis through his innovative research and patent work. His expertise lies in the inhibition of arylsulfatase, which plays a crucial role in controlling angiogenesis.

Latest Patents

Neil T. Chen holds a patent titled "Arylsulfatase inhibition and potentiation of angiostatic steroids." This patent describes a method for controlling angiogenesis by administering an effective amount of an arylsulfatase inhibitor to a mammal. The preferred arylsulfatase inhibitor is a carboxylic acid ester or a sulfuric acid ester of a benzylic alcohol. The patent emphasizes the combination of the inhibitor with an angiostatic steroid, such as hydrocortisone, and optionally with heparin to create a therapeutic composition.

Career Highlights

Throughout his career, Neil T. Chen has worked with esteemed organizations, including Children's Medical Center Corporation and Harvard College. His work has focused on developing therapeutic strategies to inhibit undesired angiogenesis, which is critical in various medical conditions.

Collaborations

Neil T. Chen has collaborated with prominent figures in the field, including Moses J. Folkman and Elias James Corey. These collaborations have furthered research in angiogenesis and its implications in medicine.

Conclusion

Neil T. Chen's contributions to the field of angiogenesis through his innovative patent and collaborations highlight his importance as an inventor. His work continues to influence therapeutic approaches in medical research.